Hybridize Therapeutics

We are Hybridize Therapeutics. We are a growing Biotech start-up on the forefront of developing innovative RNA-based therapies for kidney patients. We are driven to make a difference and prevent people from ending up with the severe consequences of kidney failure. We believe RNA therapeutics are the perfect modality to treat kidney disease. Our deep expertise & network in the field of RNA therapeutics will help us be pioneers in this field. Will you join us on our mission?